Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Epidemiological and clinical characteristics of non-severe and severe pediatric and adult COVID-19 patients across different geographical regions in the early phase of pandemic: a systematic review and meta-analysis of observational studies.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2021
   Pooled it
2. Regional and Chronological Variation of Chemosensory Dysfunction in COVID-19: a Meta-Analysis.Journal of Korean medical science · 2021
   Pooled it
3. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma.The American journal of pathology · 2020
   Trial
4. Seroprevalence of Hepatitis-E infection in healthy blood donors in an endemic country.Pakistan journal of medical sciences · 2026
   Article
5. RETRACTED: Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds.PloS one · 2024
   Article
6. Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity.Science advances · 2023
   Article
7. Associations between underlying diseases with COVID-19 and its symptoms among adults: a cross-sectional study.Frontiers in public health · 2023
   Article
8. Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines.Reviews in medical virology · 2022
   Review
9. Genomic Surveillance of SARS-CoV-2 in a University Community: Insights Into Tracking Variants, Transmission, and Spread of Gamma (P.1) Variant.Open forum infectious diseases · 2022
   Article
10. Clinical and virologic factors associated with outcomes of COVID-19 before and after vaccination among Veterans: Retrospective analysis from six New England states.Journal of hospital medicine · 2022
    Article
11. The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.International journal of biological macromolecules · 2022
    Review
12. An Update on Severe Acute Respiratory Syndrome Coronavirus 2 Diversity in the US National Capital Region: Evolution of Novel and Variants of Concern.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
13. A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients.Gene · 2022
    Article
14. Degenerate sequence-based CRISPR diagnostic for Crimean-Congo hemorrhagic fever virus.PLoS neglected tropical diseases · 2022
    Article
15. Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination.Biosensors & bioelectronics · 2022
    Article
16. Comparison of Intracellular Transcriptional Response of NHBE Cells to Infection with SARS-CoV-2 Washington and New York Strains.Frontiers in cellular and infection microbiology · 2022
    Article
17. COVID-19 adaptive evolution during the pandemic - Implications of new SARS-CoV-2 variants on public health policies.Virulence · 2021
    Article
18. Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19.International journal of molecular sciences · 2021
    Review
19. Detailed phylogenetic analysis tracks transmission of distinct SARS-COV-2 variants from China and Europe to West Africa.Scientific reports · 2021
    Article
20. Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.Genes · 2021
    Article

8 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as